Strategic buyers, private equity sponsors, and other MedTech participants entered 2025 with cautious optimism, encouraged by the potential for a pro-growth agenda and a deregulatory backdrop under a new presidential administration. Industry stakeholders hoped for renewed M&A momentum, particularly in sectors aligned with healthcare innovation and digital transformation. While this broader resurgence has yet to materialize across the M&A landscape, MedTech deal activity has begun to show meaningful momentum in 2025, as dealmakers seek to capitalize on innovations in artificial intelligence (AI), digital health platforms, and advanced surgical technologies.
Read the full article: Key Developments in MedTech M&A: Momentum Despite Macroeconomic Uncertainty //
Source: https://www.lexology.com/library/detail.aspx?g=8523e0ba-175a-4bfd-9c73-cc52b6a70edf